NGM
Zurich Cantonal Bank’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-17,511
| Closed | -$45.4K | – | 2804 |
|
|
2023
Q2 | $45.4K | Buy |
17,511
+5,995
| +52% | +$15.5K | ﹤0.01% | 2639 |
|
|
2023
Q1 | $47K | Hold |
11,516
| – | – | ﹤0.01% | 2612 |
|
|
2022
Q4 | $57.8K | Buy |
11,516
+3,476
| +43% | +$17.4K | ﹤0.01% | 2555 |
|
|
2022
Q3 | $105K | Hold |
8,040
| – | – | ﹤0.01% | 2184 |
|
|
2022
Q2 | $103K | Hold |
8,040
| – | – | ﹤0.01% | 2222 |
|
|
2022
Q1 | $123K | Sell |
8,040
-1,928
| -19% | -$29.5K | ﹤0.01% | 2185 |
|
|
2021
Q4 | $177K | Buy |
9,968
+7,907
| +384% | +$140K | ﹤0.01% | 2152 |
|
|
2021
Q3 | $43K | Buy |
2,061
+3
| +0.1% | +$63 | ﹤0.01% | 2661 |
|
|
2021
Q2 | $41K | Buy |
2,058
+85
| +4% | +$1.69K | ﹤0.01% | 2496 |
|
|
2021
Q1 | $57K | Buy |
+1,973
| New | +$57K | ﹤0.01% | 2357 |
|